These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3475498)

  • 1. Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
    Branch RA; Jackson EK; Jacqz E; Stein R; Ray WA; Ohnhaus EE; Meusers P; Heidemann H
    Klin Wochenschr; 1987 Jun; 65(11):500-6. PubMed ID: 3475498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides.
    Stein RS; Albridge K; Lenox RK; Ray W; Flexner JM
    South Med J; 1988 Sep; 81(9):1095-9. PubMed ID: 3166546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium protects against nephrotoxicity in patients receiving amphotericin B.
    Stein RS; Alexander JA
    Am J Med Sci; 1989 Nov; 298(5):299-304. PubMed ID: 2683769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.
    Branch RA
    Arch Intern Med; 1988 Nov; 148(11):2389-94. PubMed ID: 3056312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.
    Sabra R; Branch RA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1020-5. PubMed ID: 2393261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of nephrotoxicity of amphotericin B during the treatment of deep candidiasis].
    Jacqz E; Branch RA; Heidemann H; Aujard Y
    Ann Biol Clin (Paris); 1987; 45(6):689-93. PubMed ID: 3326441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B nephrotoxicity in humans decreased by salt repletion.
    Heidemann HT; Gerkens JF; Spickard WA; Jackson EK; Branch RA
    Am J Med; 1983 Sep; 75(3):476-81. PubMed ID: 6614033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients.
    Gubbins PO; Penzak SR; Polston S; McConnell SA; Anaissie E
    Pharmacotherapy; 2002 Aug; 22(8):961-71. PubMed ID: 12173799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?
    Karimzadeh I; Farsaei S; Khalili H; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2012 Nov; 11(6):969-83. PubMed ID: 22950480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of amphotericin-B-induced nephrotoxicity by loading with sodium chloride: a report of 1291 days of treatment with amphotericin B without renal failure.
    Arning M; Scharf RE
    Klin Wochenschr; 1989 Oct; 67(20):1020-8. PubMed ID: 2586007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administering amphotericin B--a practical approach.
    Khoo SH; Bond J; Denning DW
    J Antimicrob Chemother; 1994 Feb; 33(2):203-13. PubMed ID: 8182001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Must we really fear toxicity of conventional amphotericin B in oncological patients?
    Mayer J; Doubek M; Vorlìcek J
    Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
    Camp MJ; Wingard JR; Gilmore CE; Lin LS; Dix SP; Davidson TG; Geller RB
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3103-6. PubMed ID: 9835498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.
    Holler B; Omar SA; Farid MD; Patterson MJ
    Pediatrics; 2004 Jun; 113(6):e608-16. PubMed ID: 15173544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Amphotericin B-associated nephrotoxicity.
    Fisher MA; Talbot GH; Maislin G; McKeon BP; Tynan KP; Strom BL
    Am J Med; 1989 Nov; 87(5):547-52. PubMed ID: 2816970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity in rats.
    Ohnishi A; Bryant TD; Branch KR; Sabra R; Branch RA
    Antimicrob Agents Chemother; 1989 Jun; 33(6):928-32. PubMed ID: 2764543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B nephrotoxicity.
    Sabra R; Branch RA
    Drug Saf; 1990; 5(2):94-108. PubMed ID: 2182052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
    Bes DF; Rosanova MT; Sberna N; Arrizurieta E
    Pediatr Infect Dis J; 2014 Aug; 33(8):e198-206. PubMed ID: 24618932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.
    Moreau P; Milpied N; Fayette N; Ramée JF; Harousseau JL
    J Antimicrob Chemother; 1992 Oct; 30(4):535-41. PubMed ID: 1490923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.